Rat CB1 Cannabinoid Receptor-Interacting Protein 1 (CNRIP1) ELISA Kit

Product specifications

ELISA Kits

CB1 Cannabinoid Receptor-Interacting Protein 1 (CNRIP1)

Rat

Colorimetric

Quantitative

Sandwich

0.156 ng/ml - 10 ng/ml

< 0.094 ng/ml

Optimal dilutions/concentrations should be determined by the end user.

96 tests

Lyophilized

ELISA

Serum, plasma and other biological fluids.

Shipped within 5-12 working days. The validity for this kit is 6 months.

Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.

No

Q5M7A7

364208

CNRIP1,CRIP1,CRIP-1,C2orf32

Elisa kits for CNRIP1

RUO

Validity: The validity for this kit is 6 months.

This product is for research use only.   The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments.   Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein.

Descripción

Cannabinoid receptor interacting protein 1 (CNRIP1) is an intracellular protein that interacts with cannabinoid receptors, specifically CB1 (cannabinoid receptor type 1), which is primarily found in the central nervous system and plays a pivotal role in modulating various physiological processes, including pain perception, appetite, and mood. CNRIP1 is thought to be involved in regulating the signaling pathways of CB1, modulating its activity, and potentially impacting receptor desensitization or internalization. Through its interaction with CB1, CNRIP1 indirectly participates in the endocannabinoid system, which maintains homeostasis in processes such as synaptic transmission, immune response, and neuroprotection. Beyond the nervous system, CNRIP1 may also influence metabolic and energy balance functions, as CB1 receptors are expressed in peripheral tissues like adipose tissue, liver, and skeletal muscle. Aberrant expression or function of CNRIP1 has been implicated in pathological conditions such as obesity, neurodegenerative disorders, and substance use disorders, highlighting its potential as a target for therapeutic interventions. CNRIP1 continues to be an area of active research, with a focus on elucidating its precise molecular mechanisms and broader implications in cannabinoid receptor-mediated pathways.

Related Products

CNRIP1 antibody

Isoform 1 suppresses cannabinoid receptor CNR1-mediated tonic inhibition of voltage-gated calcium channels. Isoform 2 does not have this effect.

Ver Producto

Recombinant Human CNRIP1

Ver Producto

CB1 Cannabinoid Receptor-Interacting Protein 1 (CNRP1) Antibody

This gene encodes a G-protein coupled receptor which interacts with the C-terminal tail of cannabinoid receptor 1. This receptor plays a role in synaptic plasticity, analgesia, appetite, and neuroprotection. Two transcript variants encoding different isoforms have been described for this gene.

Ver Producto